U.S. Food and Drug Administration Information Sheet: “Off-Label” and Investigational Use of Marketed Drugs, Biologics, and Medical Devices (Guidance for Institutional Review Boards and Clinical Investigators. Content current as of May 5, 2020)
Accessed July 21, 2021 at: